RGLS

Regulus Therapeutics
RGLS

Overview Fund Activity
Delisted

RGLS was delisted on the 24th of June, 2025.

Back to rankings

49 hedge funds and large institutions have $58.1M invested in Regulus Therapeutics in 2017 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 12 increasing their positions, 14 reducing their positions, and 9 closing their positions.

Holders
49
Holders Change
+1
Holders Change %
+2.08%
% of All Funds
1.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
12
Reduced
14
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$1.19M
2
BI
2
BVF Inc
California
$14.5M
3
AC
3
Ascend Capital
California
$1.05M
4
LCM
4
Laurion Capital Management
New York
$408K
5
DS
5
DRW Securities
Illinois
$104K

Top Sellers

1
EC
1
EcoR1 Capital
California
$0
2
BC
2
Broadfin Capital
New York
$1.57M
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$2.56M
4
GCP
4
GSA Capital Partners
United Kingdom
$0
5
QIM
5
Quantitative Investment Management
Virginia
$47K
Name Market Value Shares Shares
Change 		Shares
Change %
ECM
51
Element Capital Management
New York
– – -504 Closed
Creative Planning
52
Creative Planning
Kansas
– – -342 Closed
ARTA
53
A.R.T. Advisors
New York
– – -207 Closed
FIM
54
Freedom Investment Management
Connecticut
– – -201 Closed
JPMorgan Chase & Co
55
JPMorgan Chase & Co
New York
– – -63 Closed
Bank of America
56
Bank of America
North Carolina
$0 3 -30 -91%
Simplex Trading
57
Simplex Trading
Illinois
– – -9 Closed
TRCT
58
Tower Research Capital (TRC)
New York
– – – –
Bank of Montreal
59
Bank of Montreal
Ontario, Canada
– – – –
Barclays
60
Barclays
United Kingdom
$0 1 – –
WTB
61
Washington Trust Bank
Washington
$0 1 +1 New
1 2
3